DK319480A - Muramylpeptidforbindelser samt deres fremstilling og anvendelse - Google Patents

Muramylpeptidforbindelser samt deres fremstilling og anvendelse

Info

Publication number
DK319480A
DK319480A DK319480A DK319480A DK319480A DK 319480 A DK319480 A DK 319480A DK 319480 A DK319480 A DK 319480A DK 319480 A DK319480 A DK 319480A DK 319480 A DK319480 A DK 319480A
Authority
DK
Denmark
Prior art keywords
muramylpeptime
compounds
preparation
muramylpeptime compounds
Prior art date
Application number
DK319480A
Other languages
English (en)
Other versions
DK161025B (da
DK161025C (da
Inventor
L Tarcsay
G Baschang
A Hartmann
J Stanek
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK319480A publication Critical patent/DK319480A/da
Publication of DK161025B publication Critical patent/DK161025B/da
Application granted granted Critical
Publication of DK161025C publication Critical patent/DK161025C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK319480A 1979-07-25 1980-07-24 Analogifremgangsmaade til fremstilling af lipophile phosphatidylmuramylpeptider DK161025C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH689379 1979-07-25
CH689379 1979-07-25
AU6658181 1981-01-23
AU66581/81A AU6658181A (en) 1979-07-25 1981-01-23 Increasing antibiotic action of antibiotics

Publications (3)

Publication Number Publication Date
DK319480A true DK319480A (da) 1981-01-26
DK161025B DK161025B (da) 1991-05-21
DK161025C DK161025C (da) 1991-10-28

Family

ID=34862371

Family Applications (1)

Application Number Title Priority Date Filing Date
DK319480A DK161025C (da) 1979-07-25 1980-07-24 Analogifremgangsmaade til fremstilling af lipophile phosphatidylmuramylpeptider

Country Status (27)

Country Link
US (2) US4414204A (da)
EP (1) EP0025495B1 (da)
JP (1) JPS5649397A (da)
KR (1) KR840001617B1 (da)
AU (2) AU541147B2 (da)
CA (1) CA1183129A (da)
CS (1) CS276965B6 (da)
CY (1) CY1381A (da)
DD (1) DD153843A5 (da)
DE (1) DE3068304D1 (da)
DK (1) DK161025C (da)
ES (1) ES493633A0 (da)
FI (1) FI75578C (da)
GR (1) GR69314B (da)
HK (1) HK85787A (da)
HU (1) HU188861B (da)
IE (1) IE50145B1 (da)
IL (1) IL60676A (da)
MX (1) MX9203368A (da)
MY (1) MY8700554A (da)
NO (1) NO157177C (da)
NZ (1) NZ194432A (da)
PL (2) PL127481B1 (da)
PT (1) PT71607A (da)
SG (1) SG38187G (da)
SU (2) SU1277905A3 (da)
ZA (1) ZA804487B (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
FI803077A7 (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (da) * 1981-01-23 1984-09-26 Ciba Geigy Ag
US5189017A (en) * 1982-07-23 1993-02-23 Ciba-Geigy Corporation Use of sugar derivatives for the prophylaxis and treatment of virus infections
ATE23536T1 (de) * 1982-07-23 1986-11-15 Ciba Geigy Ag Neue muramylpeptide und verfahren zu ihrer herstellung.
US5334583A (en) * 1982-07-23 1994-08-02 Ciba-Geigy Corp. Use of sugar derivatives for the prophylaxis and treatment of virus infections
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
US4746651A (en) * 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
ATE45744T1 (de) * 1984-07-25 1989-09-15 Ciba Geigy Ag Phosphatidylverbindungen, verfahren zu ihrer herstellung und ihre verwendung.
US4885285A (en) * 1984-09-13 1989-12-05 Ciba-Geigy Corporation Phosphorus compounds, processes for their manufacture, and their use
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US4916118A (en) * 1986-08-18 1990-04-10 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US4994440A (en) * 1989-02-13 1991-02-19 Creaven Patrick J Method for the treatment of renal cell carcinoma
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
US6156319A (en) * 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
AUPP059897A0 (en) * 1997-11-27 1998-01-08 Fujisawa Pharmaceutical Co., Ltd. New use of bicozamycin
US20040029842A1 (en) * 2001-12-18 2004-02-12 Gardner Wallace J. Triglyceride lowering, common cold and pneumonia prevention composition comprising tetracycline, and methods of treating or preventing diseases using same
AU2004262506A1 (en) 2003-02-28 2005-02-17 National Institutes Of Health Compositions, methods and kits relating to poxvirus subunit vaccines
US20050079187A1 (en) * 2003-10-14 2005-04-14 Gardner Wallace J. Composition, kit and method for reducing plaque formation, tooth decay and incidence of caries
WO2006112869A2 (en) * 2004-07-19 2006-10-26 Baylor College Of Medicine Modulation of cytokine signaling regulators and applications for immunotherapy
US7868159B2 (en) * 2005-06-23 2011-01-11 Baylor College Of Medicine Modulation of negative immune regulators and applications for immunotherapy
EP2136832B1 (en) 2007-03-26 2015-09-02 General Regeneratives Limited Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
US8324369B2 (en) * 2007-11-30 2012-12-04 Baylor College Of Medicine Dendritic cell vaccine compositions and uses of same
MX2011010050A (es) 2009-03-25 2011-12-14 Univ Texas Composiciones para estimulación de resistencia inmune innata de mamiferos a patógenos.
US9808504B2 (en) 2009-09-22 2017-11-07 Yale University Immunogenic epitopes as targets for universal cancer vaccines
AU2012321317B2 (en) 2011-07-12 2016-01-28 Inovio Pharmaceuticals, Inc Novel clostridium difficile DNA vaccine
RU2491922C1 (ru) * 2012-04-26 2013-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Способ повышения биоцидного и лечебного действия крема-суспензии с энрофлоксацином
RU2527330C2 (ru) * 2012-07-05 2014-08-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ повышения биоцидного и лечебного действия крема - суспензии с метронидазолом
WO2015116178A1 (en) 2014-01-31 2015-08-06 Thomas Jefferson University Fusion proteins for modulating regulatory and effector t cells
EP2951199A4 (en) 2013-01-31 2016-07-20 Univ Jefferson Fusion proteins for the modulation of regulatory and effector T cells
US10286065B2 (en) 2014-09-19 2019-05-14 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
CN108883080B (zh) 2015-12-15 2021-12-21 巴拉特生物技术国际有限公司 胞壁酰肽衍生物化合物、其合成及其用途
CN109640959B (zh) 2016-04-29 2023-03-17 西奈山伊坎医学院 靶向先天免疫系统以诱导长期耐受性及解决动脉粥样硬化中的巨噬细胞累积
US20220089670A1 (en) 2018-12-28 2022-03-24 University Of Rochester Gene Therapy for BEST1 Dominant Mutations
WO2022198101A1 (en) 2021-03-19 2022-09-22 Trained Therapeutix Discovery, Inc. Compounds for regulating trained immunity, and their methods of use
WO2025096754A1 (en) 2023-10-31 2025-05-08 Musc Foundation For Research Development The use of enolase inhibitor pomhex for treatment of fibrosis
WO2026015821A1 (en) 2024-07-12 2026-01-15 University Of Rochester Antibiotic alkaloid and methods of generating and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001395A (en) * 1972-06-20 1977-01-04 Agence Nationale De Valorisation De La Recherche (Anvar) Hydrosoluble extracts of mycobacteria
NL7308450A (da) * 1972-06-20 1973-12-27
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
FR2368282A1 (fr) * 1976-10-22 1978-05-19 Anvar Adjuvant immunologique constitue par le p-amino-phenyl de n-acetyl-muramyl-l-alanyl-d-isoglutamine
US4268505A (en) * 1978-04-13 1981-05-19 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith
FI803077A7 (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider

Also Published As

Publication number Publication date
AU6078880A (en) 1981-01-29
NO157177B (no) 1987-10-26
DK161025B (da) 1991-05-21
ES8105971A1 (es) 1981-07-01
CS526280A3 (en) 1992-06-17
EP0025495B1 (de) 1984-06-20
CA1183129A (en) 1985-02-26
MY8700554A (en) 1987-12-31
IE801533L (en) 1981-01-25
ES493633A0 (es) 1981-07-01
FI75578B (fi) 1988-03-31
NO802200L (no) 1981-01-26
IL60676A (en) 1984-10-31
SG38187G (en) 1988-01-15
FI802294A7 (fi) 1981-01-26
EP0025495A1 (de) 1981-03-25
MX9203368A (es) 1992-09-01
DK161025C (da) 1991-10-28
FI75578C (fi) 1988-07-11
CY1381A (en) 1987-12-18
PT71607A (de) 1980-08-01
NO157177C (no) 1988-02-03
HU188861B (en) 1986-05-28
US4406890A (en) 1983-09-27
DE3068304D1 (en) 1984-07-26
US4414204A (en) 1983-11-08
SU1277905A3 (ru) 1986-12-15
ZA804487B (en) 1981-07-29
NZ194432A (en) 1983-09-02
IL60676A0 (en) 1980-09-16
GR69314B (da) 1982-05-14
KR830003511A (ko) 1983-06-21
IE50145B1 (en) 1986-02-19
PL225870A1 (da) 1981-05-08
SU1277906A3 (ru) 1986-12-15
DD153843A5 (de) 1982-02-03
AU541147B2 (en) 1984-12-20
AU6658181A (en) 1982-11-04
PL127481B1 (en) 1983-10-31
KR840001617B1 (ko) 1984-10-11
JPS6356239B2 (da) 1988-11-07
HK85787A (en) 1987-11-27
CS276965B6 (en) 1992-11-18
JPS5649397A (en) 1981-05-02
PL131613B1 (en) 1984-12-31

Similar Documents

Publication Publication Date Title
DK319480A (da) Muramylpeptidforbindelser samt deres fremstilling og anvendelse
DK93880A (da) Polyolderivater samt deres fremstilling og anvendelse
DK287680A (da) Cyclopeptider samt deres fremstilling og anvendelse
DK211582A (da) Arylphenylether-derivater samt deres fremstilling og anvendelse
DK539979A (da) Quinazolinonderivater samt deres fremstilling og anvndelse
DK286676A (da) Bicycloheptenforbindelser samt deres fremstilling og anvendelse
DK254780A (da) Alkoxybenzylpyridopyridiner fremgangsmaade til deres fremstilling samt deres anvendelse
DK297082A (da) Substituerede 1-azolyl-2-hydroxy-alkanderivater samt deres fremstilling og anvendelse
DK318278A (da) Beta-lactamforbindelser samt deres femstilling og anvendelse
DK474678A (da) Halogenvinyl-gamma-butyrolactoner samt deres fremstilling og anvendelse
DK97179A (da) Bicyclooctanderivater samt deres fremstilling og anvendelse
DK286480A (da) Oxinethere deres fremstilling og anvendelse
DK83677A (da) Pyrrolbenzoxazalkaner samt deres fremstilling og anvendelse
DK291380A (da) Amino-thiadiazolylforbindelser samt deres fremstilling og anvendelse
DK581577A (da) Dehydrooligopeptider samt deres fremstilling og anvendelse
DK227177A (da) 1-aryloxy-2-hydroxy-3-aminopropaner samt deres fremstilling og anvendelse
DK297182A (da) Substituerede 2-hydroxy-3-azolyl-propanderivater samt deres fremstilling og anvendelse
DK319578A (da) Angiotensinpeptider samt deres fr&mstilling
DK299578A (da) Bleomyciner samt deres fremstilling og anvendelse
DK546578A (da) 2-oxo-hexahydroazepin-, -piperidin- og- pyrrolinderivater samt deres fremstilling og anvendelse
DK419084D0 (da) 2-aminomethyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK574976A (da) Substituerede cycloalkanpyrazoler samt deres fremstilling og anvendelse
DK358882A (da) Anthracyclinantibiotica samt deres fremstilling og anvendelse
DK522883A (da) 2-heterocyclylthio-alkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK84377A (da) Substituerede phenylguanidiner samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
PUP Patent expired